The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparison of dose modification strategies to address expected hematologic toxicities in treatment-naïve higher-risk (HR) MDS patients treated with venetoclax + azacitidine.
 
Jacqueline Suen Garcia
Consulting or Advisory Role - Abbvie; Astellas Pharma; Takeda
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst); Prelude Therapeutics (Inst)
 
Andrew Wei
Honoraria - Abbvie/Genentech; Amgen; Astellas Pharma; AstraZeneca; Celgene; Janssen Oncology; Macrogenics; Novartis; Pfizer; SERVIER
Consulting or Advisory Role - Abbvie/Genentech; Amgen; Astellas Pharma; AstraZeneca; Celgene; Janssen; Macrogenics; Novartis; Pfizer; SERVIER
Speakers' Bureau - Abbvie/Genentech; Celgene/Bristol-Myers Squibb; Novartis
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Novartis (Inst); Roche (Inst); Servier (Inst)
Patents, Royalties, Other Intellectual Property - AW is a former employee of the Walter and Eliza Hall Institute which receives milestone and royalty payments related to venetoclax, and is eligible for benefits related to these payments. AW receives payments from WEHI related to venetoclax
 
Uma Borate
Consulting or Advisory Role - AbbVie; Daiichi Sankyo; Genentech; Novartis; Pfizer; Takeda
Research Funding - Jazz Pharmaceuticals; Novartis; Pfizer
 
Chun Yew Fong
Honoraria - Novartis; Specialised Therapeutics
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Pfizer
Speakers' Bureau - Abbvie; Amgen; Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - Amgen
Travel, Accommodations, Expenses - Amgen
 
Maria R. Baer
Research Funding - Abbvie (Inst); AI Therapeutics (Inst); FORMA Therapeutics (Inst); Kite, a Gilead company (Inst); Oscotec (Inst); Takeda (Inst)
 
Daniel Nowak
No Relationships to Disclose
 
Pierre Peterlin
Honoraria - AbbVie; Astellas Pharma; Jazz Pharmaceuticals
Research Funding - Jazz Pharmaceuticals
 
Joseph G. Jurcic
Consulting or Advisory Role - Abbvie; Celgene; Daiichi Sankyo; Novartis
Research Funding - AbbVie (Inst); Arog (Inst); Astellas Pharma (Inst); Celgene (Inst); Daiichi Sankyo (Inst); FORMA Therapeutics (Inst); Genentech (Inst); Kura Oncology (Inst); PTC Therapeutics (Inst); Syros Pharmaceuticals (Inst)
 
Meagan Jacoby
Honoraria - Takeda
Research Funding - Abbvie (Inst); Amphivena (Inst); Aprea AB (Inst); Geron (Inst); Janssen (Inst); Jazz Pharmaceuticals (Inst)
 
Uwe Platzbecker
Honoraria - Celgene/Jazz
Consulting or Advisory Role - Celgene/Jazz
Research Funding - Amgen (Inst); BerGenBio (Inst); Celgene (Inst); Janssen (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - part of a patent for a TFR-2 antibody (Rauner et al. Nature Metabolics 2019)
Travel, Accommodations, Expenses - Celgene
 
Olatoyosi Odenike
Consulting or Advisory Role - Abbvie; Celgene; Impact Biomedicines; Novartis
Research Funding - Abbvie (Inst); Agios (Inst); Aprea AB (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Celgene (Inst); CTI BioPharma Corp (Inst); Incyte (Inst); Janssen Oncology (Inst); Kartos Therapeutics (Inst); NS Pharma (Inst); OncoTherapy Science (Inst)
 
Ilona Cunningham
Research Funding - AbbVie; Amgen; Astex Pharmaceuticals; Celgene; Janssen; Novartis; Principa Biopharma; Rigel
 
Ying Zhou
Employment - Abbvie
Stock and Other Ownership Interests - AbbVie
 
David Hoffman
Employment - Abbvie
Stock and Other Ownership Interests - AbbVie
 
Kiran Naqvi
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Steve Kye
Employment - AbbVie
Stock and Other Ownership Interests - Abbvie
 
Guillermo Garcia-Manero
Honoraria - Abbvie; Acceleron Pharma; Astex Pharmaceuticals; Celgene; Helsinn Healthcare
Consulting or Advisory Role - Acceleron Pharma; Astex Pharmaceuticals; Bristol-Myers Squibb; Celgene; Helsinn Therapeutics; Jazz Pharmaceuticals
Research Funding - Abbvie; Amphivena; Astex Pharmaceuticals; Bristol-Myers Squibb; celgene; H3 Biomedicine; Helsinn Therapeutics; Merck; Novartis; Onconova Therapeutics